Metronomic oral cyclophosphamide in patients with advanced solid tumors.

Background: Cure is rarely achieved in patients with advanced metastatic solid tumors, and quality of life including times without burdening therapies is an important endpoint. Metronomic oral cyclophosphamide (Cy) has been studied before and is a reasonable option.

Patients And Methods: 24 patients with a mean age of 64.